Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Konishi K

No contact information in database for Konishi K




    Title: In vitro deacetylation of N-acetylserotonin by arylacetamide deacetylase
    Huang Z, Li Y, Konishi K, Sakai Y, Tashiro K, Fukami T, Borjigin J
    Ref: J Pineal Res, 75:e12870, 2023 : PubMed

            

    Title: Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiency
    Nagaoka M, Fukami T, Kisui F, Yamada T, Sakai Y, Tashiro K, Ogiso T, Konishi K, Honda S and Nakajima M <2 more author(s)>
    Ref: Biochemical Pharmacology, 195:114842, 2022 : PubMed

            

    Title: Bacterial triacylglycerol lipase is a potential cholesterol esterase: Identification of a key determinant for sterol-binding specificity
    Yasutake Y, Konishi K, Muramatsu S, Yoshida K, Aburatani S, Sakasegawa SI, Tamura T
    Ref: Int J Biol Macromol, 167:578, 2021 : PubMed

            

    Title: Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment
    Konishi K, Minematsu T, Nagasaka Y, Tabata K
    Ref: Biopharmaceutics & Drug Disposition, 40:176, 2019 : PubMed

            

    Title: Production of recombinant extracellular cholesterol esterase using consistently active promoters in Burkholderia stabilis
    Yoshida K, Konishi K, Magana-Mora A, Rougny A, Yasutake Y, Muramatsu S, Murata S, Kumagai T, Aburatani S and Tamura T <1 more author(s)>
    Ref: Biosci Biotechnol Biochem, 83:1974, 2019 : PubMed

            

    Title: In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injury
    Konishi K, Fukami T, Ogiso T, Nakajima M
    Ref: Biochemical Pharmacology, 155:242, 2018 : PubMed

            

    Title: Physiologically-based pharmacokinetic modeling for mirabegron: a multi-elimination pathway mediated by cytochrome P450 3A4, uridine 5'-diphosphate-glucuronosyltransferase 2B7, and butyrylcholinesterase
    Konishi K, Minematsu T, Nagasaka Y, Tabata K
    Ref: Xenobiotica, :1, 2018 : PubMed

            

    Title: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
    Kitada M, Tsuda SI, Konishi K, Takeda-Watanabe A, Fujii M, Kanasaki K, Nishizawa M, Nakagawa A, Koya D
    Ref: BMJ Open Diabetes Res Care, 5:e000391, 2017 : PubMed

            

    Title: Identification of enzymes responsible for nitrazepam metabolism and toxicity in human
    Konishi K, Fukami T, Gotoh S, Nakajima M
    Ref: Biochemical Pharmacology, 140:150, 2017 : PubMed

            

    Title: Complete Genome Sequence of Burkholderia stabilis FERMP-21014
    Konishi K, Kumagai T, Sakasegawa SI, Tamura T
    Ref: Genome Announc, 5:, 2017 : PubMed

            

    Title: Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity
    Fukami T, Iida A, Konishi K, Nakajima M
    Ref: Biochemical Pharmacology, 116:153, 2016 : PubMed

            

    Title: Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain
    Hachisu M, Konishi K, Hosoi M, Tani M, Tomioka H, Inamoto A, Minami S, Izuno T, Umezawa K and Hori K <1 more author(s)>
    Ref: Neurodegener Dis, 15:182, 2015 : PubMed

            

    Title: Demonstrating the Role of Anticholinergic Activity in a Mood Disorder
    Hori K, Konishi K, Hanashi T, Tani M, Tomioka H, Kitajima Y, Akashi N, Inamoto A, Kurosawa K and Hachisu M <4 more author(s)>
    Ref: Neurodegener Dis, 15:175, 2015 : PubMed

            

    Title: Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity
    Hosoi M, Hori K, Konishi K, Tani M, Tomioka H, Kitajima Y, Akashi N, Inamoto A, Kurosawa K and Hachisu M <3 more author(s)>
    Ref: Neurodegener Dis, 15:157, 2015 : PubMed

            

    Title: Plasma Cholinesterase Activity in Alzheimer's Disease
    Hosoi M, Hori K, Konishi K, Tani M, Tomioka H, Kitajima Y, Akashi N, Inamoto A, Minami S and Hachisu M <3 more author(s)>
    Ref: Neurodegener Dis, 15:188, 2015 : PubMed

            

    Title: Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease
    Konishi K, Hori K, Tani M, Tomioka H, Kitajima Y, Akashi N, Inamoto A, Kurosawa K, Yuda H and Hachisu M <3 more author(s)>
    Ref: Neurodegener Dis, 15:149, 2015 : PubMed

            

    Title: Identification and characterization of prokaryotic dipeptidyl-peptidase 5 from Porphyromonas gingivalis
    Ohara-Nemoto Y, Rouf SM, Naito M, Yanase A, Tetsuo F, Ono T, Kobayakawa T, Shimoyama Y, Kimura S and Nemoto TK <3 more author(s)>
    Ref: Journal of Biological Chemistry, 289:5436, 2014 : PubMed

            

    Title: Donepezil Abolishes Anticholinergic Activity in a Patient with Amnesia
    Konishi K, Hori K, Tomioka H, Minegishi G, Tani M, Tanaka H, Akita R, Yokoyama S, Oshio T, Hachisu M
    Ref: Pharmacology, 91:86, 2012 : PubMed

            

    Title: Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence
    Kumagai Y, Konishi K, Gomi T, Yagishita H, Yajima A, Yoshikawa M
    Ref: Infect Immun, 68:716, 2000 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer